We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
-17.42%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$266M
AUM Growth
-$59.6M
Cap. Flow
-$347K
Cap. Flow %
-0.13%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
+$347K

Sector Composition

Rank Sector Weight
1 Healthcare 91.79%
2 Miscellaneous 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$144M 54.16%
2,111,111
– –
EPZM
2
DELISTED
Epizyme, Inc
EPZM
$79.8M 29.97%
9,166,667
– –
EPZM
3
CALL
DELISTED
Epizyme, Inc
EPZM
$21.9M 8.21%
2,511,477
+2,156
+0.1% +$22.3K
CYTK icon
4
Cytokinetics
CYTK
$10.8B
$20.4M 7.65%
875,656
– –
VIRX
5
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$34K 0.01%
3,700
-33,305
-90% -$347K

Similar funds

PC
Paradoxiom Capital Stamford, Connecticut $154M AUM
LA
LPF Advisors Sarasota, Florida $122M AUM 3.12% 1-Year Est. Return
TP
Thunderbird Partners London, United Kingdom $113M AUM 8.51% 1-Year Est. Return
SC
Serenity Capital Palo Alto, California $167M AUM
MADFP
Michael A Dubis Financial Planning Middleton, Wisconsin $103M AUM
RM
RCF Management Denver, Colorado $103M AUM
NC
Napatree Capital Westerly, Rhode Island $178M AUM 8.09% 1-Year Est. Return
GWA
GGM Wealth Advisors Baltimore, Maryland $180M AUM 10.57% 1-Year Est. Return

RP Management's Q1 2021 Portfolio in Review

As of Q1 2021, RP Management held 5 positions worth $266M, down 18% from $326M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2021: portfolio turnover was 0%. RP Management opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 92% a quarter earlier, followed by Miscellaneous.

  • RP Management's biggest Q1 2021 reduction was Viracta Therapeutics, Inc. Common Stock, cutting an estimated $347K.
  • RP Management's ten largest holdings make up 100% of its $266M portfolio in Q1 2021.
  • RP Management opened 0 new positions and closed 0 in Q1 2021.
  • RP Management's portfolio value fell 18% quarter-over-quarter to $266M.

Based on RP Management's 13F filing for Q1 2021, filed 17 May 2021.